Matthew R. Plooster - Jun 17, 2021 Form 4 Insider Report for KEMPHARM, INC (ZVRA)

Role: Director
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Matthew R. Plooster
Stock symbol: ZVRA
Transactions as of: Jun 17, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/21/2021, 08:35 AM
Next filing: Dec 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZVRA	Stock Option (right to buy)	Award	$0	+15K		$0.00	15K	Jun 17, 2021	Common Stock	15K	$15.47	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 17, 2021.
F2	This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's sixth amended and restated non-employee director compensation policy.
F3	One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.